Ivan Gut
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
Papers in
- Pharmacology 26
- Pharmacogenetics and Drug Metabolism 24
- Drug-Induced Hepatotoxicity and Protection 5
- Oncology 22
- Drug Transport and Resistance Mechanisms 15
- Cancer Treatment and Pharmacology 9
- Co-authors
- Pavel Souček (32 shared papers)Radka Václavíková (15 shared papers)Marie Ehrlichová (13 shared papers)Petr Šimek (5 shared papers)Pavel Anzenbacher (2 shared papers)Ján Kopecký (10 shared papers)Pavel Stopka (4 shared papers)Jan Kovár̆ (8 shared papers)
- Journals
- Archives of Toxicology (10 papers)Xenobiotica (3 papers)Biochemical Pharmacology (3 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)Investigational New Drugs (2 papers)
- Partner nations
- CzechiaVietnamUnited States
In The Last Decade
Ivan Gut
66 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 115
- Pharmacology 686
- Cancer Research 426
- Oncology 638
- Biochemistry 166
- Chemical Health and Safety 14
Countries citing papers authored by Ivan Gut
This map shows the geographic impact of Ivan Gut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Gut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Gut more than expected).
Fields of papers citing papers by Ivan Gut
This network shows the impact of papers produced by Ivan Gut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Gut. The network helps show where Ivan Gut may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Gut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 225 | |
| 2 | Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. | 1998 | 139 |
| 3 | 1994 | 136 | |
| 4 | 2013 | 121 | |
| 5 | 2003 | 102 | |
| 6 | 2004 | 93 | |
| 7 | 1975 | 62 | |
| 8 | 2016 | 62 | |
| 9 | 2003 | 59 | |
| 10 | 2000 | 57 | |
| 11 | 1996 | 56 | |
| 12 | 2011 | 50 | |
| 13 | 1999 | 46 | |
| 14 | 1996 | 46 | |
| 15 | 2007 | 44 | |
| 16 | 2004 | 44 | |
| 17 | 1993 | 39 | |
| 18 | 2005 | 37 | |
| 19 | RNA expression of cytochrome P450 in breast cancer patients. | 2008 | 33 |
| 20 | 1994 | 33 |
About Ivan Gut
Ivan Gut is a scholar working on Pharmacology, Oncology, Molecular Biology, Cancer Research and Biochemistry, having authored 67 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (24 papers), Drug Transport and Resistance Mechanisms (15 papers), Carcinogens and Genotoxicity Assessment (11 papers), Cancer Treatment and Pharmacology (9 papers), Metabolism and Genetic Disorders (7 papers), Sulfur Compounds in Biology (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). The work is most often cited by research in Pharmacology (686 citations), Cancer Research (426 citations), Oncology (638 citations), Biochemistry (166 citations) and Chemical Health and Safety (14 citations). Ivan Gut has collaborated with scholars based in Czechia, Vietnam and United States. Frequent co-authors include Pavel Souček, Radka Václavíková, Marie Ehrlichová, Petr Šimek, Pavel Anzenbacher, Ján Kopecký, Pavel Stopka, Jan Kovár̆, E Frantík and Roman Kodet. Their work appears in journals such as Archives of Toxicology, Xenobiotica, Biochemical Pharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.